LeonaBio Statistics
Total Valuation
LeonaBio has a market cap or net worth of $65.20 million. The enterprise value is $14.71 million.
| Market Cap | 65.20M |
| Enterprise Value | 14.71M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LeonaBio has 9.42 million shares outstanding. The number of shares has increased by 233.81% in one year.
| Current Share Class | 9.42M |
| Shares Outstanding | 9.42M |
| Shares Change (YoY) | +233.81% |
| Shares Change (QoQ) | +24.70% |
| Owned by Insiders (%) | 9.34% |
| Owned by Institutions (%) | 43.29% |
| Float | 4.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.94 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.01 |
| Quick Ratio | 6.53 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -431.39% and return on invested capital (ROIC) is -101.92%.
| Return on Equity (ROE) | -431.39% |
| Return on Assets (ROA) | -74.07% |
| Return on Invested Capital (ROIC) | -101.92% |
| Return on Capital Employed (ROCE) | -111.60% |
| Weighted Average Cost of Capital (WACC) | 15.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$7.45M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.63% in the last 52 weeks. The beta is 2.05, so LeonaBio's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | +81.63% |
| 50-Day Moving Average | 7.86 |
| 200-Day Moving Average | 7.55 |
| Relative Strength Index (RSI) | 37.97 |
| Average Volume (20 Days) | 76,509 |
Short Selling Information
The latest short interest is 40,293, so 0.43% of the outstanding shares have been sold short.
| Short Interest | 40,293 |
| Short Previous Month | 38,973 |
| Short % of Shares Out | 0.43% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 0.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.77M |
| Pretax Income | -141.46M |
| Net Income | -141.46M |
| EBITDA | -53.83M |
| EBIT | -54.77M |
| Earnings Per Share (EPS) | -$10.88 |
Balance Sheet
The company has $51.07 million in cash and $577,000 in debt, with a net cash position of $50.49 million or $5.36 per share.
| Cash & Cash Equivalents | 51.07M |
| Total Debt | 577,000 |
| Net Cash | 50.49M |
| Net Cash Per Share | $5.36 |
| Equity (Book Value) | 33.60M |
| Book Value Per Share | 3.57 |
| Working Capital | 46.99M |
Cash Flow
| Operating Cash Flow | -61.93M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 944,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -61.93M |
| FCF Per Share | -$6.57 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LeonaBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -233.81% |
| Shareholder Yield | n/a |
| Earnings Yield | -216.96% |
| FCF Yield | -94.98% |
Analyst Forecast
The average price target for LeonaBio is $17.33, which is 150.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.33 |
| Price Target Difference | 150.43% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Sep 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |